Jiang Nan Shi Bao
Search documents
长三角三项考古发现入围2025年中国考古新成果
Jiang Nan Shi Bao· 2026-02-09 23:21
纵览2025年中国考古新成果,一个个新成果刷新着相关历史认知,也勾勒出绵延不绝的文明长卷。 江南时报讯 中国社会科学院近日公布"2025年中国考古新成果"。全国共有七个项目入围,其中三项来 自长三角地区,分别是江苏无锡斗山新石器时代遗址、浙江绍兴越国都城遗址和浙江嘉兴东塔寺遗址。 斗山新石器时代遗址的发现是2025年考古界的重要新发现之一。该遗址的发现,把长江下游史前城址的 年代推进到距今6000年前。斗山遗址于2023年在无锡市新锡快速路工程的考古前置调查中被发现,总面 积约25万平方米。2025年9月7日,斗山遗址考古现场专家论证会在无锡召开,16位专家形成专家意见, 认为斗山遗址考古"揭示了马家浜和崧泽文化时期的城墙、高等级墓葬等重要遗迹"。目前,联合考古队 对斗山遗址的考古发掘仍在继续。 越国都城遗址位于绍兴古城南部,主要包括稽中与和畅坊两处发掘点。2024年至2025年,考古团队在稽 中遗址共发掘4000平方米,首次揭露出东周时期越国宫台建筑基址及汉六朝时期会稽郡官署建筑遗存。 在和畅坊遗址,考古人员首次发现东周时期越国宫城城墙体系与高等级祭祀遗迹。 东塔寺是嘉兴城市历史上的重要地标,是其近郊规模最 ...
如何保证安全和营养?预制菜将迎首个国家标准
Jiang Nan Shi Bao· 2026-02-09 23:05
江南时报讯 随着预制菜工业化、规模化、标准化生产的出现和快速发展,如何保证预制菜的安全性和 营养品质,成为公众关注的焦点。近日,国家卫生健康委发布《食品安全国家标准——预制菜》(征求 意见稿),重点从食品安全和营养健康方面对预制菜产品作出规定。 国家食品安全风险评估中心标准二室主任、研究员王君介绍,标准明确,预制菜不包括主食类食品、净 菜类食品、即食类食品和中央厨房制作的菜肴。预制菜应具有菜肴的特征,因此排除主食类产品;应具 有"经工业化预加工"的特征,仅经清洗、去皮、分切处理的净菜类食品,未改变其作为原料的基本属 性,所以排除了净菜类食品;应具有"需加热或熟制后食用"的特征,所以排除了开袋即食的食品。此 外,预制菜应具有预包装产品属性,中央厨房相当于门店自有厨房,故中央厨房制作的菜肴未纳入预制 菜范围。但是,中央厨房使用外购的、工业化的、现成的预制菜产品除外。 标准特别设置了对预制菜保质期的条款。为保证预制菜产品的安全和营养品质,标准条款中列举了保质 期设定时应综合考虑的各项因素,并鼓励企业通过优化产品工艺和贮藏运输方式等措施提升产品风味和 品质保持。统筹考虑公众期待、营养品质、风味口感和产业发展等因素,标 ...
张家港农商银行深化政银协同 赋能个体经济
Jiang Nan Shi Bao· 2026-02-09 21:51
自2023年起,张家港农商银行与当地市监局、市私个协建立紧密协作机制,立足各自职能与资源优势, 创新服务模式,联合策划并深入开展"个体工商户网格化大走访"活动。活动中,该行工作人员与市场监 管网格员协同作战,通过"政策宣讲面对面、服务供给点对点、共筑发展心连心"的务实举措,成功推动 了"金融服务网格"与"市场监管网格"的"两网"深度融合。截至目前,已累计成功帮助超过3500户个体工 商户获得融资支持,为全市广大市场主体注入宝贵的金融活水,有力激发了个体私营经济的生机与活 力。 下一步,该行将继续坚守"服务地方、服务小微、服务民生"的市场定位,持续深化与政府各部门、协会 组织的战略合作,不断优化服务流程、创新金融产品,将"网格化"走访服务机制做深、做实、做细,努 力为张家港市实体经济的高质量发展贡献更加强劲的金融力量。尤婕妤周雅 近日,张家港农商银行收到来自张家港市场监督管理局与市私营个体经济协会的联合感谢信。信中表 示,市私个协在2025年被中国个体劳动者协会评为"问情服务"活动表现突出单位,此项荣誉的取得,与 张家港农商银行小微金融部同市场监督管理局共同发起并持续推进的"服务上门"大走访活动密不可分。 ...
以旧换新显实效 江苏智能家电零售额增长32.9%
Jiang Nan Shi Bao· 2026-02-09 17:05
Group 1 - The core viewpoint is that Jiangsu Province is implementing a robust "old for new" policy in 2025, leading to double-digit growth in retail sales of certain green and smart products [1] - The overall retail sales of consumer goods in Jiangsu Province are projected to reach 46,394.2 billion yuan in 2025, with a year-on-year growth of 3.3% [1] - Key categories driving growth include new energy vehicles (21.2%), energy-efficient products (39.5%), smart home appliances (32.9%), and computers (34%), collectively contributing 3.4 percentage points to the overall retail sales growth [1] Group 2 - Online retail is experiencing rapid growth, with total online retail sales expected to reach 13,739.1 billion yuan in 2025, marking a year-on-year increase of 7.8% [2] - The online retail of physical goods is projected to be 11,317.7 billion yuan, growing by 5%, which is 1.7 percentage points higher than the overall retail sales growth [2] - The provincial statistics bureau emphasizes the need to enhance consumer policies, innovate consumption scenarios, and boost consumer willingness to further unleash demand potential [2]
江苏发布2026年度民生实事项目
Jiang Nan Shi Bao· 2026-02-09 16:23
Core Insights - The Jiangsu provincial government announced the 2026 annual livelihood projects, with over half of the projects being newly proposed, marking the highest proportion in history [1][2]. Group 1: Project Characteristics - The 2026 livelihood projects consist of 12 categories and 45 items, focusing on public service standards and addressing citizens' immediate needs [1]. - Emphasis is placed on small-scale, community-oriented projects that directly address the daily concerns of citizens, such as free dental care for eligible children and the installation of elevators in existing residential buildings [1][2]. Group 2: Implementation Strategy - The government aims to enhance inter-departmental collaboration and streamline processes, with 18 projects requiring joint efforts from multiple departments, the highest number to date [1]. - A series of significant actions are proposed, including mental health initiatives for youth and employment enhancement programs, aiming for effective resolution of community issues [1][2]. Group 3: Sustainability and Effectiveness - The projects are designed with a long-term perspective, with 44 items having clear goals for the next 3-5 years, and 21 items included in the "14th Five-Year Plan" [2]. - There is a focus on integrating technology into these projects, such as AI training for youth and smart transportation initiatives, to enhance the quality of life [2]. Group 4: Financial Commitment - The total funding required for the 2026 livelihood projects is approximately 18.3 billion yuan, with assurances from the provincial finance department for budget allocation and financial support [3]. - The government commits to a sustained effort over 3-5 years to ensure the successful implementation of these projects, aiming to improve public satisfaction and address pressing community needs [3].
全国首批!无锡华厦眼科成功落地EVO+ICL(V5)新技术
Jiang Nan Shi Bao· 2026-02-09 13:48
Core Viewpoint - The introduction of the EVO+ICL (V5) implantable contact lens in Wuxi marks a significant advancement in myopia correction, particularly for patients with night vision issues, providing a more personalized and precise solution [1][3]. Group 1: Product Introduction - The EVO+ICL (V5) lens is recognized as an "optimized version for night vision" and has been successfully implanted in Wuxi, with the first surgery performed by Dr. Gu Yong [1]. - This new lens aims to enhance night vision quality and offers a solution for myopia patients who struggle with night-time visibility [1][3]. Group 2: Patient Experience - Ms. Lin, the first patient to receive the EVO+ICL (V5) lens, experienced significant improvement in her night vision, allowing her to resume activities like night running without the hindrance of glare and distortion [2]. - The surgery was completed in approximately ten minutes, and her vision improved to 1.0 shortly after the procedure [2]. Group 3: Key Upgrades - The EVO+ICL (V5) features two major upgrades: enhanced night vision quality through an optimized optical zone design, and improved precision in correcting myopia for patients with lower degrees of myopia [3]. - The lens design reduces night-time visual disturbances such as halos and glare, benefiting individuals who drive or work at night [3]. Group 4: Target Patient Demographics - The EVO+ICL (V5) is particularly suitable for five types of patients: those with high night vision requirements, larger dark pupils, myopia between 50-1400 degrees, thin corneas, and those seeking a non-corneal cutting correction method [5]. - The introduction of this lens provides a more personalized choice for patients, emphasizing the importance of individualized assessments prior to surgery [5]. Group 5: Technical Requirements - The EVO+ICL (V5) lens requires a higher level of surgical expertise due to its larger optical zone, necessitating precise evaluations of various ocular parameters by the surgeon [7]. - Wuxi Huaxia Eye Hospital, led by a specialized team, is committed to offering high-quality, personalized eye care services, including the new EVO+ICL (V5) lens [7].
方舟云康:科技领跑“AI+慢病服务”赛道,以硬核实力实现稳健盈利
Jiang Nan Shi Bao· 2026-02-09 08:48
近年来,人工智能技术的快速发展与深度应用,为慢病管理领域带来了革命性发展机遇,深刻改变了传 统健康服务的模式与边界。作为国内领先的"AI+慢病服务"平台,方舟云康控股有限公司(下称:方舟云 康)以前瞻性战略布局和持续的技术创新,不仅实现了业绩的稳健增长与全面盈利,更逐步构建起一套 以用户为中心、以技术为驱动、以信任为基石的全场景健康管理服务体系,为行业发展注入新动能。 展望未来,随着人口老龄化加剧与慢病高发趋势凸显,中国慢病管理市场规模预计2030年将突破6000亿 元,市场潜力巨大。方舟云康打造的可信赖全程管理服务模式,契合行业发展趋势,具备长期发展确定 性。加之AI技术持续赋能带来的升级潜力,方舟云康的长期发展价值正日益凸显,有望在未来持续领 跑"AI+慢病服务"赛道,为更多患者提供更优质、更高效、更便捷的健康服务。 基于"熟人医患"模式,方舟云康建立起以H2H(Hospital to Home从医院到家庭)为核心的智慧医疗生态体 系,通过"健客医生""健客医院""方舟健客网上药店"三大APP协同发力,公司提供的服务覆盖慢病管 理、健康科普、药事服务等关键环节,实现了健康服务的全场景渗透与闭环落地。 20 ...
如何打造韧性城市?江苏出台三年行动方案
Jiang Nan Shi Bao· 2026-02-09 06:44
Core Viewpoint - Jiangsu Province has launched an action plan to advance new urban infrastructure construction and enhance urban resilience from 2026 to 2028, aiming for significant progress in smart municipal facilities and urban safety resilience systems [1][2]. Group 1: Key Goals - By the end of 2028, the action plan sets several core targets, including achieving a 75% effective coverage rate for urban lifeline safety projects, constructing over 300 complete communities, and fostering more than three smart construction industry clusters [1]. - The plan aims for approximately 60% application of smart construction technologies in major projects and over 80% coverage of smart management in large-scale engineering projects, with 100% coverage of urban operation management service platforms at provincial, municipal, and county levels [1]. Group 2: Specific Initiatives - The action plan focuses on nine major enhancement actions to build a comprehensive resilient urban construction system, including the development of smart municipal infrastructure and the integration of intelligent sensing devices in underground networks, bridges, and utility tunnels [2]. - It also emphasizes the collaborative development of smart cities and intelligent connected vehicles, with plans to cover 2,800 kilometers of vehicle networking and upgrade 600 kilometers of smart roads, while establishing urban smart logistics and emergency material support systems [2]. Group 3: Smart Construction and Industrialization - Another core direction is the collaborative development of smart construction and building industrialization, with support for the establishment of smart construction industrial parks in cities like Nanjing and Suzhou, aiming to cultivate 80 related enterprises [3]. - The action plan includes detailed measures for digital home upgrades, urban information model (CIM) platform construction, and the enhancement of urban operation management service platforms, such as requiring new fully furnished residences to include basic smart products [3].
中国创新药崛起不可逆 四大投资方向或值得深挖
Jiang Nan Shi Bao· 2026-02-09 05:59
Core Viewpoint - The Chinese innovative pharmaceutical sector is expected to reach a historical high in 2025 with a total transaction amount exceeding $135.6 billion and an upfront payment of approximately $7 billion, leading to a valuation recovery in the sector [1] Group 1: Market Outlook - The optimistic outlook for the pharmaceutical sector in 2026 is based on the dual logic of global pharmaceutical innovation cycles and the enhancement of China's industrial competitiveness [2][3] - The global pharmaceutical industry is currently experiencing a major innovation cycle, with advancements in gene editing, antibody screening, and targeted drug delivery technologies driving new drug development [2] Group 2: Competitive Position - China's biopharmaceutical industry has entered the global innovative drug competition, with the country ranking second in the global pharmaceutical market and accounting for about 30% of innovative drugs under research [3] - The systemic advantages in R&D efficiency, engineering talent, and clinical resources in China's biopharmaceutical sector are establishing long-term competitive strengths [3] Group 3: Investment Opportunities - The overall valuation recovery in the pharmaceutical sector may be nearing its end, with future investment opportunities likely to arise from structural opportunities with alpha attributes [4] - Four key areas identified for potential alpha generation include next-generation tumor immunotherapy, advancements in antibody-drug conjugates (ADCs), the evolution of weight loss drugs, and the expansion of small nucleic acid drugs into common chronic diseases [4][5] Group 4: AI Integration - AI is enhancing the pharmaceutical sector by improving R&D efficiency, with successful applications in early drug discovery and potential for significant returns by shortening development cycles and reducing costs [7] - The integration of AI tools in drug development is expected to yield substantial benefits during patent protection periods, enhancing project return rates [7] Group 5: Investment Strategy - The investment strategy should focus on selecting assets with unique core competencies, particularly in areas like bispecific antibodies and ADCs, which are globally scarce and in high demand from multinational pharmaceutical companies [8] - The traditional notion that "domestic products are inferior to imports" is being challenged, as China is now competitive in several innovative drug segments [9]
实干笃行三十载,跃向未来再出发
Jiang Nan Shi Bao· 2026-02-08 13:34
伴着"十五五"开局的奋进号角,踏着金融服务中国式现代化和强国建设的铿锵步伐,南京银行迎来成立30周年的历史时 刻! 1996年2月8日,南京银行从古城金陵39家城市信用社的合并改制起步,成为国内首批设立的城商行之一。30年来,发轫 于金融改革洗礼,成长于经济腾飞浪潮,南京银行深刻诠释"服务地方经济、服务中小企业、服务城乡居民"的初心使 命,把自身成长融入城市发展、企业壮大、人民幸福的时代底色,实现了从地方银行到国内系统重要性银行的蜕变,谱 写了城商行改革发展的壮美篇章。 30年倾力奉献,情系民生践行金融担当。连续15年、累计捐资2020万元,开展"圆梦行动"慈善助学活动;冠名支持南京 马拉松、世界田联室内锦标赛等城市体育盛事,与广大市民共享金融增益;开展金融知识进社区、进校园活动,构建安 全和谐的金融生态环境……持续践行"责任金融、和谐共赢"的文化理念。南京银行的30年,是一部初心为民、反哺社会 的责任史。 扎根地方 积微成著 铸就跨越发展 30年峥嵘淬炼,创新基因根植发展血脉。2001年,率先引入国际金融公司投资入股,创下单一外资股东持股比例新高; 2005年,牵手战略投资者法国巴黎银行,打造中外金融合作典 ...